Clinical Profiles and Early Outcomes of Living Kidney Donors With Pre‐Existing Type 2 Diabetes
Clinical Transplantation · 2026
DOI: 10.1111/ctr.70732 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, 2026. Verfasst von Bonnie E Lonze und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, NYU Langone Health, New York, New York, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Living Donors, Kidney Transplantation, Kidney Failure, Chronic. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Alvin Thomas was supported by a grant from the National Institutes of Health.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
In 2022, Organ Procurement and Transplantation Network policy was revised to permit living kidney donation by carefully selected individuals with type 2 diabetes mellitus (T2DM), which had previously been prohibited. Early evaluation is needed to understand adoption of this practice and short‐term donor outcomes.
Methods
We performed a retrospective cohort study using U.S. national transplant registry data. Living kidney donors with and without pre‐existing T2DM from July 26, 2022 through December 31, 2025 were compared. We examined prevalence, temporal trends, donor characteristics, and early post‐donation outcomes. Five registry‐captured chronic kidney disease risk factors at donation were assessed: insulin dependence, smoking, hypertension, body mass index ≥30 kg/m 2 , and proteinuria.
Results
Among 21,827 donors, 46 (0.21%) had T2DM at donation. T2DM incidence increased from 7 donors in 2022 (0.11%) to 17 (0.26%) in 2025. T2DM donors were older than non‐T2DM donors (median 54y vs. 45y; p < 0.001), and 87% of T2DM donors had ≥1 additional risk factor for CKD. No T2DM donors died, initiated dialysis, or were added to the transplant waiting list. Median most recent eGFR within 2 years was 61 vs. 66 mL/min/1.73m 2 in donors with and without T2DM ( p = 0.20). eGFR
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, NYU Langone Health, New York, New York, USA.
- Transplant Institute, NYU Langone Health, New York, New York, USA.
- Department of Medicine, NYU Langone Health, New York, New York, USA.
- Department of Population Health, NYU Langone Health, New York, New York, USA.
Förderung
- Alvin Thomas was supported by a grant from the National Institutes of Health
Zitieren
APA
Lonze, B. E., Husain, S. A., Newsome, J. B., Thakur, M., Weiss, S. A., Ali, N. M., Levan, M. L., Thomas, A. G., Orandi, B. J., Reed, R. D., Massie, A. B., Segev, D. L., & Stewart, D. E. (2026). Clinical Profiles and Early Outcomes of Living Kidney Donors With Pre‐Existing Type 2 Diabetes. Clinical Transplantation. https://doi.org/10.1111/ctr.70732
Vancouver
Lonze BE, Husain SA, Newsome JB, Thakur M, Weiss SA, Ali NM, et al. Clinical Profiles and Early Outcomes of Living Kidney Donors With Pre‐Existing Type 2 Diabetes. Clinical Transplantation. 2026. doi:10.1111/ctr.70732
BibTeX
@article{Lonze2026,
author = {Lonze, Bonnie E and Husain, Syed Ali and Newsome, Jacey B and Thakur, Madhur and Weiss, Samantha A and Ali, Nicole M and Levan, Macey L and Thomas, Alvin G and Orandi, Babak J and Reed, Rhiannon D and Massie, Allan B and Segev, Dorry L and Stewart, Darren E},
title = {Clinical Profiles and Early Outcomes of Living Kidney Donors With Pre‐Existing Type 2 Diabetes},
journal = {Clinical Transplantation},
year = {2026},
doi = {10.1111/ctr.70732}
}
EUVIMED